The Beat Live at HLTH: Driving Meaningful Progress in Health Equity—featuring Judith Kulich
About Judith Kulich:
Judith serves as ZS’s lead for patient health and equity, focused on partnering with clients across the healthcare industry to drive meaningful progress in health equity. She is also an elected member of ZS’s Shareholders’ Council where she serves as the chair of the ESG Committee and leads the ZS Practice Council.
Judith has spent much of her 20-plus years in the healthcare industry focused on drug development and bringing medicines to market globally. In recent years, she has expanded her work into healthcare payers and providers, bringing sectors together to address disparities in care and global health inequities. She has led industry collaborations and ZS’s investments and actively contributed to global health equity partnerships.
Judith established and ran ZS’s pipeline and launch strategy practice area. Internally, she led ZS’s San Francisco office and was one of the founders of Women@ZS and our philanthropic arm, ZS Cares, both of which she is still actively involved in today.
Judith holds an MBA from the Haas School of Business at the University of California, Berkeley, and a B.S. in industrial engineering and operations research from the University of California, Berkeley.
Things You’ll Learn:
- 74,000 black Americans die every year in the United States due to inequities.
- The economic costs of health inequities in the US are over $300 billion annually.
- There is a lack of representation among minority groups.
- There is also a lack of training and incentives to adopt behaviors that bolster equity across healthcare.
- A third of patients who drop out of their care do so because of drivers of health like transportation, food, and housing, which require their partial or full financial support.
- The other two-thirds of patients that drop out of their programs need help with awareness and care coordination.
- Life sciences stakeholders can expand sites of care and increase representation to improve access.
- Targeting specific disease areas and communities is a great start to closing disparity gaps.
Resources: